Sleep Promotion and Pediatric Hypertension
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age13-18
SponsorChildren's Hospital of Philadelphia
About this trial
Determine the effectiveness and feasibility of a mobile health sleep extension approach in the pediatric nephrology setting, to increase sleep duration and reduce systolic and diastolic blood pressure.
Eligibility criteria
Qualifiers
Speak, read and write in English.
Parental/guardian permission (informed consent) and child assent.
Have a computer or a tablet computer with access to the Internet or own a smartphone with a data and text plan.
Parent reported sleep duration on school nights less than or equal to 7.5 hours.
Disqualifiers
Any clinically diagnosed sleep disorder (e.g. sleep apnea) in the electronic health record and or regular use of prescribed sleep aide.
Underlying chronic medical conditions, defined as a medical condition with a duration or expected duration longer than 3 months that involved taking regular medication, taking medications that could affect blood pressure (e.g., anti-hypertensive medications, glucocorticoids, or stimulants), and patients with underlying diagnoses known to be associated with elevated blood pressure (e.g., cardiac disease, kidney disease or diabetes).
Be the parent/guardian of an eligible child enrolled in the main study.
Speak, read, and write in English.
Trial design
Treatments tested in this trial
- Intervention
Treatment groups
10 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov